Camurus AB
STO:CAMX

Watchlist Manager
Camurus AB Logo
Camurus AB
STO:CAMX
Watchlist
Price: 511.5 SEK 1.29% Market Closed
Market Cap: 30.1B SEK

EV/EBIT
Enterprise Value to EBIT

43.4
Current
53.9
Median
16.3
Industry
Lower than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
43.4
=
Enterprise Value
27.3B SEK
/
EBIT
629.4m SEK
Market Cap EV/EBIT
SE
Camurus AB
STO:CAMX
30.1B SEK 43.4
US
Eli Lilly and Co
NYSE:LLY
699.1B USD 37
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 17 702.3
US
Johnson & Johnson
NYSE:JNJ
373.4B USD 16.4
DK
Novo Nordisk A/S
CSE:NOVO B
2T DKK 15.3
CH
Roche Holding AG
SIX:ROG
211.2B CHF 11.2
CH
Novartis AG
SIX:NOVN
184.2B CHF 13.8
UK
AstraZeneca PLC
LSE:AZN
166.2B GBP 197.5
US
Merck & Co Inc
NYSE:MRK
193.3B USD 10.1
IE
Endo International PLC
LSE:0Y5F
163.5B USD 655.3
US
Pfizer Inc
NYSE:PFE
133.5B USD 10.3
EBIT Growth EV/EBIT to Growth
SE
Camurus AB
STO:CAMX
Average EV/EBIT: 1 701.2
43.4
84%
0.5
US
Eli Lilly and Co
NYSE:LLY
37
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.4
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
15.3
14%
1.1
CH
Roche Holding AG
SIX:ROG
11.2
6%
1.9
CH
Novartis AG
SIX:NOVN
13.8
10%
1.4
UK
AstraZeneca PLC
LSE:AZN
197.5
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.1
11%
0.9
IE
E
Endo International PLC
LSE:0Y5F
655.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
10%
1

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
25.7
2-Years Forward
EV/EBIT
14.1
3-Years Forward
EV/EBIT
9.4